Subscribe to Newsletter

Clinical Trials

Discovery & Development Clinical Trials

Clinical Trials and Digital Doubles

| 5 min read

Digital twins in clinical trials are changing how research is performed – but it won’t be a revolution, according to Phesi CEO Gen Li.
Discovery & Development Clinical Trials

Inhibitors Versus Diabetes … And Dementia!

| Rob Coker

Research suggests diabetes patients using SGLT-2 and DPP-4 inhibitors have a decreased risk of developing dementia.
Business & Regulation Digital Technologies

The Changing Landscape of Decentralized Clinical Trials

| Diane Leclerc | 2 min read

How technology is enabling new access to clinical trials for those without the means to participate in traditional methods
Discovery & Development Drug Discovery

The Speed of Success

| 4 min read

If used correctly, AI and ML expand our knowledge of biology and vastly improve the speed of success in the clinic.
Discovery & Development Clinical Trials

Harnessing AI for Pharma's Next Leap

| Tero Laulajainen | 3 min read

Discussing the finer points of AI as a catalyst for pharmaceutical innovation
Discovery & Development Clinical Trials

The Art of Prescreening

| 5 min read

How does prescreening improve clinical trials? Cara Brant, CEO of Clinical Trial Media, explains.
Discovery & Development Clinical Trials

Don’t Forget the Elderly

| Sharmeen Roy | 4 min read

Older adults are underrepresented in clinical trials. This needs to change.
Discovery & Development Clinical Trials

For Faster Trials, Improve Feasibility

| Christine Senn | 6 min read

The burden on clinical trials designers and healthcare professionals can only be eased by fixing a broken process: trial feasibility.
Discovery & Development Clinical Trials

Regeneron on the Digital Age of Clinical Trials

| 6 min read

The world is taking more interest in clinical trials. How are clinical trials adapting? Regeneron’s Bari Kowal keeps us updated.
Discovery & Development Clinical Trials

Clinical Arms

| 4 min read

Phesi CEO Gen Li discusses the impacts of the conflict between Russia and Ukraine on clinical trials

Latest White Papers

Direct-to-Patient (DtP) Clinical Trials – Using RTSM Systems to Overcome Supply Challenges

| Contributed by 4G Clinical

Accelerate recruitment with a decentralized clinical trial strategy

| Contributed by Thermo Fisher Scientific

Performance validation of ScatterX78 against NIST reference materials

| Contributed by Malvern Panalytical

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

October Issue of The Medicine Maker